I concur; the immediate goal to is to obtain proper funding on the Balance sheet. AMBS has a vast pipeline; it wont miss one of those key assets if it can progress many others going forward. I reiterate that the right decisions were made with the DX transactions (first decent mgt. decision in a long time).
Pipeline is stunning...but it wont matter without the right capital and funding structure (as the stock price has suffered and reflects reality).
(7)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links